Autopsy report · NCT03170219

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

“Slow enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 5 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Adrian Hernandez

Sponsor type

University, hospital or other

Conditions

Acute Heart Failure; Decompensated Heart Failure

Interventions

subcutaneous furosemide and sc2wear device

Participants

11

Sites

16

Countries

United States

Trials that died the same way

• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.